SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-006508
Filing Date
2023-10-30
Accepted
2023-10-27 18:04:14
Documents
2
Period of Report
2023-10-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_102723.htm 6-K 8018
2 EXHIBIT 99.1 exh_991.htm EX-99.1 4278
  Complete submission text file 0001171843-23-006508.txt   13297
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 231356694
SIC: 2834 Pharmaceutical Preparations